Carregant...
A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy
Combination immunotherapy has recently emerged as a powerful cancer treatment strategy. A promising treatment approach utilizes coadministration of antagonistic antibodies to block checkpoint inhibitor receptors, such as antiprogrammed cell death-1 (aPD1), alongside agonistic antibodies to activate...
Guardat en:
| Publicat a: | Adv Mater |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003883/ https://ncbi.nlm.nih.gov/pubmed/29691900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.201706098 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|